TAP expression provides a general method for improving the recognition of malignant cells in vivo

Nature Biotechnology

Volumn 18, Issue 5, 2000, Pages 515-520

  Alimonto, Judy ^a   Zhang, Qian Jin ^a   Gabathuler, Reinhard ^a   Reid, Gregor ^a   Chen, Susan S ^a   Jefferies, Wilfred A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cancer therapy; Carcinoma; CTL; Immunosurveillance; MHC; TAP

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; ENDOPLASMIC RETICULUM; GENE CONSTRUCT; IMMUNOSURVEILLANCE; LUNG SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; VACCINIA VIRUS;

ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, SMALL CELL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOTHERAPY; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, INBRED C57BL; MONITORING, IMMUNOLOGIC; PHENOTYPE; TRANSFECTION;

ANIMALIA; VACCINIA; VACCINIA VIRUS;

EID: 0034068643     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/75373     Document Type: Article

References (23)

1. Tanaka, K., Isselbacher, K.J., Khoury, G. & Jay, G. Reversal of ontogenesis by the expression of a major histocompatibility complex class I gene. Science 228, 26 (1985).
2. Wallid, R. et al. Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigen following H-2 gene transfection. Nature 315, 301-305 (1985).
3. Seliger, B., Maeurer, M.J. & Ferrone, S. TAP off-Tumors on. Immunol. Today 18, 292 (1997).
4. Garrido, F. et al. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol. Today 18, 89 (1997).
5. Hammerling, G.J., Klar, D., Pulm, W., Momburg, F. & Moldenhauer, G. The influence of major histocompatibility complex class I on tumor growth and metastasis. Biochim. Biophys. Acta 907, 245 (1987).
6. Singal, D.P., Ye, M. & Qiu, X. Molecular basis for lack of expression of HLA class I antigen in human small-cell lung carcinoma cell lines. Int. J. Cancer 68, 629 (1996).
7. Braciale, T.J. & Braciale, V.L. Viral antigen presentation and MHC assembly. [Review]. Semin. Immunol. 4, 81-84 (1992).
8. Rammensee, H.G. Antigen presentation - recent developments [Review]. Int. Arch. Allergy Immunol. 110, 299-307 (1996).
9. Momburg, F., Roelse, J., Neefjes, J. & Hammerling, G.J. Peptide transporters and antigen processing [Review]. Behring Inst. Mitteilungen (1994).
10. Neefjes, J.J., Schumacher, T.N. & Ploegh, H.L. Assembly and intracellular transport of major histocompatibility complex molecules [Review]. Curr. Opin. Cell Biol. 3, 601-609 (1991).
11. Cromme, F.V. et al. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J. Exp. Med. 179, 335-340 (1994).
12. Maeurer, M.J. et al. Tumour escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen. J. Clin. Invest. 98, 1633 (1996).
13. Seliger, B. et al. Expression and function of the peptide transporters in escape variants of human renal cell carcinomas. Exp. Hematol. 25, 608 (1997).
14. Wang, R.F. & Rosenberg, S.A. Human tumor antigens recognized by T lymphocytes: implications for cancer therapy. J. Leuk. Biol. 60, 296-309 (1996).
15. Franks, L.M., Carbonell, A.W., Hemmings, V.J. & Riddle, P.N. Metastasizing tumors from serum-supplemented and serum-free cell lines from a C57B1 mouse lung tumour. Cancer Res. 36, 1049 (1976).
16. 2-microglobulin by interferon-gamma. EMBO J. 8, 475 (1989).
17. 2-microglobulin and antigenic peptides. J. Immunol. 151, 2974-2985 (1993).
18. Gabathuler, R., Reid, G., Kolaitis, G., Driscoll, J. & Jefferies, W.A. Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing. J. Exp. Med. 180, 1415-1425 (1994).
19. Reid, G.S.D. Functional relevance and structural requirements of peptide transport in a murine carcinoma cell line (PhD Thesis). (Biotechnology Laboratory, Univ. of British Columbia, Vancouver, BC, Canada; 1997).
20. Vose, B.M. & Moose, M. Human tumor-infiltrating lymphocytes: a marker of host response. Semin. Haematol. 22, 27-40 (1985).
21. Inglis, J.R. T Lymphocyte today.(Elsevier Science Publisher, Amsterdam, The Netherlands; 1983).
22. Mackett, M. & Smith, G.L. Vaccinia virus expression vectors. J. Gen. Virol. 67, 2067-2082 (1986).
23. SAS Institute, Inc. JMP IN version 3.2.1. (Duxbury Press, Pacific Grove, CA; 1989-1997).